Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 296

1.

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents.

Tashkin DP, Fabbri LM.

Respir Res. 2010 Oct 29;11:149. doi: 10.1186/1465-9921-11-149. Review.

2.

Therapeutic potential for novel ultra long-acting β2-agonists in the management of COPD: biological and pharmacological aspects.

Malerba M, Radaeli A, Morjaria JB.

Drug Discov Today. 2012 May;17(9-10):496-504. doi: 10.1016/j.drudis.2011.11.002. Epub 2011 Nov 18. Review.

PMID:
22119310
3.

Long-acting beta-agonists and their association with inhaled corticosteroids in COPD.

Fuso L, Mores N, Valente S, Malerba M, Montuschi P.

Curr Med Chem. 2013;20(12):1477-95. Review.

PMID:
23409722
4.

Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD.

Keam SJ, Keating GM.

Treat Respir Med. 2004;3(4):247-68. Review.

PMID:
15350163
5.

Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.

Ohar JA, Donohue JF.

Semin Respir Crit Care Med. 2010 Jun;31(3):321-33. doi: 10.1055/s-0030-1254072. Epub 2010 May 21. Review.

PMID:
20496301
7.

Long-acting beta2-agonists for chronic obstructive pulmonary disease.

Kew KM, Mavergames C, Walters JA.

Cochrane Database Syst Rev. 2013 Oct 15;(10):CD010177. doi: 10.1002/14651858.CD010177.pub2. Review.

PMID:
24127118
8.

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.

Beier J, Beeh KM.

Int J Chron Obstruct Pulmon Dis. 2011;6:237-43. doi: 10.2147/COPD.S7371. Epub 2011 Apr 12. Review.

9.

Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.

Kerwin EM, Williams J.

Ther Adv Respir Dis. 2013 Feb;7(1):25-37. doi: 10.1177/1753465812470018. Epub 2013 Jan 7. Review.

PMID:
23296242
10.

The short, the long and the "ultra-long": why duration of bronchodilator action matters in chronic obstructive pulmonary disease.

Beeh KM, Beier J.

Adv Ther. 2010 Mar;27(3):150-9. doi: 10.1007/s12325-010-0017-6. Epub 2010 Apr 19. Review.

PMID:
20411368
11.

Comparative efficacy of indacaterol in chronic obstructive pulmonary disease.

Ribeiro M, Chapman KR.

Int J Chron Obstruct Pulmon Dis. 2012;7:145-52. doi: 10.2147/COPD.S19805. Epub 2012 Mar 5. Review.

12.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Karner C, Cates CJ, Evans DJ.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD007033. doi: 10.1002/14651858.CD007033.pub3. Review.

PMID:
22161409
13.

Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.

Spencer S, Evans DJ, Karner C, Cates CJ.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007033. doi: 10.1002/14651858.CD007033.pub2. Review. Update in: Cochrane Database Syst Rev. 2011;(12):CD007033.

PMID:
21975759
14.

The safety of long-acting β2-agonists in the treatment of stable chronic obstructive pulmonary disease.

Decramer ML, Hanania NA, Lötvall JO, Yawn BP.

Int J Chron Obstruct Pulmon Dis. 2013;8:53-64. doi: 10.2147/COPD.S39018. Epub 2013 Jan 25. Review.

15.

Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.

Boscia JA, Pudi KK, Zvarich MT, Sanford L, Siederer SK, Crim C.

Clin Ther. 2012 Aug;34(8):1655-66.e5. doi: 10.1016/j.clinthera.2012.06.005. Epub 2012 Jul 11.

PMID:
22789766
16.
17.

Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety.

Rossi A, Khirani S, Cazzola M.

Int J Chron Obstruct Pulmon Dis. 2008;3(4):521-9. Review.

18.

Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease.

Ramadan WH, Kabbara WK, El Khoury GM, Al Assir SA.

Int J Chron Obstruct Pulmon Dis. 2015 Oct 30;10:2347-56. doi: 10.2147/COPD.S88246. eCollection 2015. Review.

19.

The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: current evidence and future prospects.

Feldman GJ, Edin A.

Ther Adv Respir Dis. 2013 Dec;7(6):311-9. doi: 10.1177/1753465813499789. Epub 2013 Sep 3. Review.

PMID:
24004659
20.

Indacaterol therapy in moderate-to-severe chronic obstructive pulmonary disease: findings from a single-center primary care cohort.

Singh MP.

Int J Chron Obstruct Pulmon Dis. 2013;8:613-9. doi: 10.2147/COPD.S53707. Epub 2013 Dec 9.

Supplemental Content

Support Center